Form4insider filings, from the source

SEC Form 4 · accession 0001213900-26-070248

Cadrenal Therapeutics, Inc. · CVKD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Quang X Pham
Officer — Chairman, CEO and Interim CFO · Director · 10% Owner
Period of report
Jun 16, 2026
Accepted (ET)
Jun 18, 2026 · 6:36 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001937993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 16, 2026S3,613$3.18D129,102D
Common StockF1,F3Jun 17, 2026S513$3.16D128,589D
Common StockF4holding———200,000IThe PVBQ Living Trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses